Bed Rest After Preterm Premature Rupture of the Membranes
A Pilot Randomized Controlled Trial On Complete Bed Rest Versus Activity Restriction After Preterm Premature Rupture of the Membranes
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
Antepartum bed rest is widely prescribed after preterm premature rupture of the membranes (PPROM), although its effectiveness to prevent preterm birth has not been demonstrated. This pilot randomized controled trial (RCT) aims to access the impact of bed rest in maternal and neonatal outcomes in pregnancies complicated by premature rupture of the membranes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 23, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2019
CompletedJanuary 30, 2019
January 1, 2019
5.9 years
November 23, 2018
January 28, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Latency time
Time between preterm premature rupture of the membranes and delivery, in days
From preterm premature rupture of the membranes until delivery, estimated average time of one week
Chorioamnionitis
Incidence of clinical chorioamnionitis (defined as maternal fever plus leukocytosis and CRP elevation, or as maternal fever plus any two of the following: fetal tachycardia; maternal tachycardia; uterine tenderness; purulent amniotic fluid)
From preterm premature rupture of the membranes until delivery, estimated average time of one week
Study Arms (2)
Complete bed rest
EXPERIMENTALParticipants on complete bed rest group kept antepartum confinement to bed with toileting restricted to bedpan use. Participants in this group received prophylactic subcutaneous enoxaparin (40mg/day).
Activity restriction group
EXPERIMENTALActivity restriction group had motion limited to bathroom privileges and walks to the ward canteen four times per day.
Interventions
Patients in this group received standard care for PPROM according to the institution protocol, including antepartum confinement to bed.
Patients in this group received standard care for PPROM according to the institution protocol but to had bathroom privileges and walks to the ward canteen four times per day.
Eligibility Criteria
You may qualify if:
- single pregnancies AND
- PPROM at 24+0-33+6 weeks of gestation AND
- admitted to our tertiary center.
You may not qualify if:
- indication for immediate delivery on admission (chorioamnionitis, placenta abruption, cord prolapse, signs of fetal hypoxia/distress)
- fetal malformations
- multiple gestation
- maternal immunosuppressive disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, Principal Investigator
Study Record Dates
First Submitted
November 23, 2018
First Posted
January 24, 2019
Study Start
January 1, 2012
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
January 30, 2019
Record last verified: 2019-01